It has been hoped that amniotic epithelial cells would be a gene carrier to neural and hepatic tissue, because of 1) the presence of neural and hepatic stem-like cells, 2) the ability to cryopreserve them, 3) long-term survival in the transplanted site, and 4) few ethical problems concerning procurement. But transplantation of a sufficient number of cells to adult tissue needs large-scale cell supply and may lead to vascular embolism. We attempted transplantation of amniotic epithelial cells into fetal liver, because 1) the fetal liver is at the proliferative stage, 2) the number of cells required is small, and 3) the fetal stage is advantageous for the induction of immunological tolerance. Amniotic epithelial cells from day 18.5-20.5 fetuses were transfected with adenoviral AdlacZ and harvested to inject into fetal rat liver of the syngeneic strain (day 18.5-20.5). The efficacy of cell transplantation into the liver increased in the order: intraplacental < intraumbilical vein < intrahepatic route. LacZ-transfected amniotic cells (1-8 × 10 5 cells), hepatocytes (5 × 10 5 cells), or AdlacZ vector solution (1.7 × 10 7 pfu) were injected through the uterine membrane into the liver. Transplanted cells formed a cellular mass and survived for up to 14 days after birth, whereas lacZ-transfected cells were rapidly decreased after the injection of AdlacZ vector or rat hepatocytes as a gene carrier so that the use of amniotic epithelial cells as a gene carrier will result in long-term expression of exogenous genes in the liver.
INTRODUCTION
granuloma, and, from the ethical point of view, procurement of the cells is easier than that of other materials of One of the therapeutic strategies for severe congenital human origin. In this study we optimized the route of metabolic disorders is prenatal treatment of the fetus, transplantation of amniotic epithelial cells into fetal rat termed in utero manipulation (7) . Because fetal tissues liver by in utero manipulation and characterized the celare highly proliferative and possibly contain stem cells lular behavior and exogenous gene expression in the or multipotential immature cells, the possible advantages liver, comparing them with those of other types of cells of the in utero manipulation are the amenability of inteand viral vector treatment. gration of foreign DNA, potential for immunological tolerance induction, as well as prevention of the onset MATERIALS AND METHODS of pathological changes due to metabolic abnormality. It Animals has been hoped that amniotic epithelial cells would be a gene carrier to certain organs or tissues, because there Inbred LEW rats (SEAC Yoshitomi, Fukuoka, Japan) were used throughout the experiments. The day of mat-are hepatic and neural stem-like cell populations (9,10). Indeed, experimental gene therapy succeeded in the re-ing was confirmed by detection of a vaginal plug and regarded as gestation day 0.5. Delivery was observed at pair of brain tissue of a mucopolysaccharidosis model mouse, by using genetically engineered amniotic epithe-day 21.5 in most cases. All experimental procedures were designed according to our institutional animal eth-lial cells (4). Amniotic epithelial cells have several biological and clinical advantages other than the presence ics guidelines based on the NIH guidelines (12). Surgical treatments were performed under ethyl ether anes-of stem-like cells; the cells are biologically inert and survive in tissues without forming either neoplasm or thesia. 444 TAKAHASHI ET AL.
Isolation, Culture, and Storage of Amniotic Cells antibodies to the adenovirus vector (human type V adenovirus) was determined by a neutralizing test (3). Rat amniotic epithelial cells were prepared as described previously (6) . Briefly, yolk sac-free amniotic RESULTS membrane was isolated from fetuses at gestation days Examination of Route of Injection for Cell 18.5-20.5 and digested with collagenase (2 mg/ml, Col-Transplantation Into Liver lagenase S-I, Nitta Gelatin, Tokyo, Japan). The isolated Aiming to transplant cells into the liver, we examined cell viability judged by the trypan blue exclusion test three different methods: intraplacental, intraumbilical always exceeded 95%, and 2 × 10 6 cells were inoculated vein, and intrahepatic injections (Table 1) . Although all in a 100-mm cell culture dish (Falcon 3003, Bectonthree routes are fetus sites, no injected cells were detect-Dickinson, NJ, USA) with DMEM/F12 medium (12400able in the neonatal organs with intraplacental injection. 081, Gibco BRL, Grand Island, NY, USA) containing
As well as amniotic cells, rat hepatocytes did not mi-10% fetal bovine serum, 100 units of penicillin G, 100 grate from the placenta to the liver and other organs µg/ml of streptomycin, and 100 µg/ml of kanamycin (data not shown). After intraumbilical vein injection, the (15140-122 and 15160-054, respectively, Gibco BRL).
cells were mainly recovered in the heart rather than in After 1-2 days of culture, the adherent cells were harthe liver (Table 1 , Fig. 2B , C), probably due to the distrivested and frozen to store in liquid nitrogen. Two to 3 bution of umbilical blood flow between the vena cava days before cell transplantation, the stored cells were inferior and the portal vein. The most reliable transplanthawed and cultured with DMEM/F12 as above. The vitation of the cells was achieved by direct intrahepatic ability of the thawed cells was 80-90% in a trypan blue injection through the uterus membrane ( . with adenoviral vector AdlacZ at an MOI of 10, as described previously (6). To compare the migration rate Outcome of Intrahepatic Injection of Amniotic with that of various other types of cells, rat primary cul-Epithelial Cells by In Utero Manipulation ture hepatocytes were used. Isolation and cell culture Table 2 summarizes the birth rate and other data on were performed as described elsewhere (2) and transfecfetuses after in utero manipulation. The average number tion of the lacZ gene was achieved as above 1 day beof fetuses was 11.1 ± 3.1 (mean ± SD) at gestation age fore transplantation.
of 18.5-20.5 days. After in utero manipulation, the date of delivery was retarded approximately 1 day from Transfection of Adenovirus Vector (AdexlacZ) the normal delivery date (day 21.5) and the birthrate was and Cell Transplantation Into Rat Fetus 49.4 ± 22.9% on average (18.2-84.6%). Some rats were The cells and viral vector were transplanted into rat born dead and the discrepancy between the numbers of fetuses by three different routes: 1) injection into the treated fetuses and live and dead infants was likely to placenta, 2) injection into the umbilical vein, and 3) inbe due to absorption of dead fetuses or being eaten by jection into the fetal liver. In groups 1 and 3, injection the mother rat just after delivery. was performed through the uterus membrane into the placenta or liver at gestation age 18.5-20.5 days (out-Histological Examination of Survival of Transplanted lined in Fig. 1 ) and fetuses and neonates were tended by Cells, Compared With Transfection of Adenoviral their original maternal rats. In group 2, day 20.5 fetus Vector, AdlacZ was taken outside and injected cells through the umbili-
The time course change in transplanted amniotic epical vein by means of a microsyringe (705LT50µlSYR, thelial cells that had been transfected with lacZ by ade-Hamilton, Reno, NV, USA) with a disposable needle noviral vector was examined (Fig. 3) . One and 2 weeks (KF730NDL6/PK(30/2″/2), Hamilton). The treated feafter delivery, the cells formed a spheroidal mass ( Fig.  tuses were nursed by a foster mother that had delivered 3B, C). Interestingly, amniotic cells had gradually miwithin the previous 2 days. Rat tissues were sampled at grated into the hepatic parenchyma by 2 weeks later the day indicated and frozen for histological examina- (Fig. 3C) . The cells in the mass were thought to be alive, tion.
because no sign of necrosis or related changes, such as leukocyte infiltration, was observed in hematoxlin-eosin Miscellaneous staining samples (data not shown). Amniotic cells existed up to 4 weeks after birth, although the cellular Detection of lacZ-transfected cells was performed by staining with X-gal solution (6), followed by hematoxy-mass disappeared and only migrated cells remained (data not shown). Exogenous lacZ gene expression in lin staining. Color development of X-gal staining was done at 37°C for 3 h in all cases. The serum titer of hepatocytes that had been transfected with AdlacZ is Figure 1 . Outline of in utero manipulation in rats. Pregnant LEW rats usually have 11.1 ± 3.1 fetuses (see Table 2 ), and cells or adenovirus vectors were injected into the placenta or liver of all littermates (P, placenta, L, liver, N, needle). In the case of intraumbilical vein injection, day 20.5 fetuses were nursed by a foster mother after the treatment.
shown in Figure 3E and F. Although X-gal-positive cells 3F). In contrast, the intensity of X-gal staining was unchanged in amniotic cells even 2 weeks after delivery. composed approximately 25% of the total sight on the day of delivery (2 days after transfection by in utero To compare cell mobility, syngeneic rat hepatocytes were also injected (Fig. 3G ). Although the tissue was manipulation) (Fig. 3E) , the ratio and intensity of X-gal staining was much weaker 1 week after delivery ( Fig.  damaged 2 h after the injection, a strong large cellular mass existed, and almost all cells were cleared by 1 day ond injection of adenoviral vector. Some rats had a higher titer (128-fold) than those with one-shot chal-later ( Fig. 3H ). Neither hepatic tissue transfected with AdlacZ nor injected with hepatocytes showed inflamma-lenge of AdlacZ. tory reaction such as leukocytes infiltration and edema.
DISCUSSION Antibody Response to AdlacZ by Rats Treated
Because fetal treatment requires a highly cautious With Exogenous Gene Transfection by technique, the treatment should be uncomplicated and In Utero Manipulation noninvasive. Among transplantation routes examined, direct injection into the target organ, the liver, was the Because adenoviral vector is originally produced from human type V adenovirus, normal juvenile rats did most effective and reproducible. Although the ratio of umbilical blood outflow into the vena cava inferior and not have anti-adenovirus antibodies. But once injected intravenously via the tail vein (1.6 × 10 9 pfu), the titer portal vein was reported to be 55% and 45% in fetal lambs (8), the distribution of injected amniotic epithelial rose to 8-to 64-fold by 4 weeks after the transfection (Fig. 4) . In the in utero manipulation group, neither in-cells inclined to the heart in rats. In addition, the presence of an arterial duct accelerated the cell accumula-jection of AdlacZ nor transplantation of amniotic epithelial cells that had been transfected with AdlacZ raised tion. Intraplacental injection was technically the easiest, but there was no evidence of cell migration, unlike in a antibody for 4 weeks. But exposure of AdlacZ during the gestation period was not necessarily capable of in-recent report on the transplacental injection of somitederived cells (11). The nature of the cells, especially the ducing immunological tolerance, as shown by the sec- the AdlacZ-transfected liver (Fig. 3E, F) , and in utero transfection did not raise antibodies to the adenovirus (Fig. 4 ). In addition, exposure to the adenovirus during the fetal stage was not likely to induce immunological tolerance (Fig. 4) . Because hepatocytes are still highly proliferative in the neonatal stage, the disappearance of transfected cells is mainly due to cell division, although there may be some other mechanisms. The expression of exogenous genes transfected into amniotic epithelial cells lasted in the liver more persistently than either AdlacZ-transfected hepatocytes or the transplantation of transfected hepatocytes. Adenoviral transfection has potential risks, which were unfortunately manifested in a clinical incident (5). Therefore, ex vivo gene therapy coupled with appropriate carrier cells, such as amniotic epithelial cells for hepatic and neural tissue, will facilitate the development of clinical trials in the near future.
